ALLOPURINOL Uses Warning Side effects Precautions Overdose & Brands
Watsons Health

ALLOPURINOL

Allopurinol is used for treating hyperuricaemia and gout. It reduces the formation of uric acid in purine metabolism without disturbing the production of important purines.

Allopurinol minimizes uric acid formation by blocking xanthine oxidase that acts as a catalyst in converting hypoxanthine to xanthine and finally to uric acid. As it blocks xanthine oxidase enzyme, uric acid production will be considerably reduced.

Allopurinol is prescribed to treat gout and hyperuricaemia.

Do not give this drug to people with the following conditions:

  • Acute gout attack
  • Renal and hepatic impairment
  • Pregnancy and lactation

Allopurinol may have the following side effects:

Precautions

Take extra caution in patients with the following medical conditions:

  • Renal and hepatic impairment
  • Pregnancy and lactation

 

Interactions

Allopurinol may interact with the following medicines:

  • Mercaptopurine
  • Azathioprine
  • Warfarin and other coumarin anticoagulants
  • Salicylates or uricosuric agents
  • Thiazide diuretics,
  • Some antibacterials
  • Antineoplastics
  • Ciclosporin
  • Sulfonylurea antidiabetics
  • Theophylline
  • Vidarabine

If you think you have used  Allopurinol drug more than the normal dosage, please seek medical help immediately.

 

Available Brands:

Allurase, Alpurase, Llanol, Loricid, Prinol, Purinase, RiteMED Al and Urinol Zyloprim

Related Articles

HUMAN PAPILLOMAVIRUS 9-VALENT VACCINE

The 9-valent vaccine against the human papillomavirus (HPV) is a non-infectious adjuvanted vaccine made using recombinant technology. It contains inactive [...]

HUMAN PAPILLOMAVIRUS VACCINE (TYPE 6, 11, 16, 18)

The quadrivalent vaccine against the human papillomavirus (HPV) is a non-infectious adjuvanted vaccine made using recombinant technology. It contains inactive [...]

HIB CONJUGATE VACCINE (MENINGOCOCCAL PROTEIN CONJUGATE)

HiB Conjugate Vaccine (Meningococcal Protein Conjugate) induces the development of anticapsular antibodies, which protect against infection with Haemophilus influenzae type [...]